An observational study in Inflammation, Magnesium Deficiency and Iron-deficiency, sponsored by Glasgow Royal Infirmary. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2020-04-28.
Sponsored by Glasgow Royal Infirmary · Observational
We wish to determine to what extent magnesium, thiamine and transketolase activity are affected by the Systemic Inflammatory Response (SIR). The knee arthroplasty model affords the ideal study design, as surgery generates an inflammatory response.
Blood samples are drawn preoperatively and for up to four days post operatively, and again at three months post-operation.
Thiamine and magnesium play a critical role in glucose metabolism and deficiency results in the accumulation of anaerobic metabolites including lactate (1-3).
Thiamine requires magnesium to be converted to its active form, thiamine pyrophosphate (TPP) (4). TPP also requires magnesium to achieve activation of TPP dependent enzymes during metabolism of glucose (5, 6). The 'gold standard' for the measurement of thiamine status is the measurement of Erythrocyte Transketolase Activity (ETKA)(4, 7-9), and this enzyme's activity is dependent on the presence both thiamine pyrophosphate and magnesium (8, 10). ETKA may therefore represent a 'functional marker' of magnesium status (7, 9, 11, 12).
Studies indicate that low plasma thiamine and magnesium are associated with a range of disease processes, many of which are inflammatory (13-17). Other lipid-soluble vitamins and minerals are known to decrease during the systemic inflammatory response (18, 19), however this relationship is not proven for magnesium. The systemic inflammatory response may therefore confound the interpretation of plasma thiamine and magnesium in the context of sepsis, surgery or autoimmune disease. Elective knee arthroplasty, provokes an inflammatory response and therefore provides an excellent controlled model for understanding the body's response to a systemic insult (19).
Obesity is reported to be associated with magnesium deficiency (17, 20). Intracellular magnesium plays a key role in regulating insulin action, insulin-mediated-glucose-uptake and vascular tone (21-23). Several epidemiologic studies have shown that adults and children consuming a western type diet are consuming 30 - 50% of the RDA for magnesium (24, 25). This deficiency appears to be predominantly subclinical and therefore not routinely investigated.
Obesity is also associated with thiamine and magnesium depletion (17, 20, 26, 27). Magnesium deficiency is also associated with a CRP rise (28-30). Thiamine status is proven to affect lactate concentrations in the blood (2, 3). Lactate accumulation is known to precede the onset of insulin resistance and be characteristically found in patients with obesity related diabetes (31-37).
It is therefore possible that an underlying quiescent magnesium and / or thiamine deficiency may mediate insulin resistance. Thiamine, and its more lipid soluble derivative, benfothiamine, have already shown some promise in the treatment of diabetic complications. The therapeutic potential is intriguing, however the relation between acute changes in the systemic inflammatory response and thiamine and magnesium concentrations, require clarification. Failure to prove the reliability of the thiamine and magnesium measurements in the context of the systemic inflammatory response may lead to patients receiving treatment for a measured deficiency of red cell thiamine and serum magnesium concentrations, which is unreliable. If the therapeutic potential of combined treatment with thiamine and magnesium for the optimization of ETKA function is to be realized (8), it is essential that the erythrocyte and plasma values used to determine thiamine status are definitively established in the context of the systemic inflammatory response. The knee arthroplasty model affords the ideal study design for this as there is a strong association between obesity and knee osteoarthritis (38, 39).
24 studies on the registry are indexed under Magnesium Deficiency; 2 are open to participants now.
Browse Magnesium Deficiency studies →Glasgow Royal Infirmary is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Compared within Magnesium Deficiency, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Inflammation. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Patients undergoing elective TKR
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Post total knee replacement patients
Diagnostic Test: Blood draw
We take blood samples at pre-op and subsequent time points, up to three months post op.
serum magnesium
blood sample
Time frame: three months
thiamine
blood sample
Time frame: three months
erythrocyte transketolase activity
blood sample
Time frame: three months
Iron receptor status
blood sample
Time frame: three months
Plan to share: No — We will publish anonymised results. No patient identifiable data will be shared.
This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Glasgow Royal Infirmary